Invivyd

Invivyd (operating at invivyd.com) is a biopharmaceutical company specializing in antibody-based therapies designed to combat evolving viral threats. Founded with a mission to outpace viral mutations, Invivyd develops medicines that are more potent and resistant than the human immune system. Headquartered in New Haven, the company leverages proprietary integrated technology to engineer therapies capable of adapting to emerging pathogens. This approach allows healthcare providers and vulnerable populations—particularly immunocompromised individuals—to access advanced protection strategies against serious viral infectious diseases. By focusing on rapid, adaptive antibody solutions, Invivyd addresses a critical gap in global health security, offering a proactive defense mechanism against rapidly mutating viruses like COVID-19.